The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Swain, N Engl J Med 353(26):2807-2809 December 29, 2005.

Correction
PreviousPrevious
Volume 355:533 August 3, 2006 Number 5
NextNext

Aromatase Inhibitors — A Triumph of Translational Oncology

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Swain, S. M.
Aromatase Inhibitors — A Triumph of Translational Oncology . On page 2807, the sentence that begins five lines from the bottom of the right-hand column should have read, "The Italian Anastrozole Trial (ITA), with a median follow-up of 36 months, compared 2 to 3 years of tamoxifen followed by 2 to 3 years of anastrozole with 5 years of tamoxifen and found that sequential treatment increased recurrent-free survival by 5.8 percentage points," not "reduced recurrent-free survival," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.